Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-831 in Male Hepatitis C Carriers (CP104)
NCT00522808Phase 2Terminated
- Sponsor
- Arrow Therapeutics
- Start
- Aug 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of A-831 in hepatitis C virus infection, sponsored by Arrow Therapeutics. Started Aug 2007; status: terminated.
02
Drugs
A-831
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00522808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522808.